Synthesis, Antioxidant Activity, and Molecular Docking of Novel Paeoniflorin Derivatives
Jiating Ni,Meng Yang,Xinyue Zheng,Mingtao Wang,Qian Xiao,Hua Han,Peiliang Dong
DOI: https://doi.org/10.1111/cbdd.14629
2024-09-28
Chemical Biology & Drug Design
Abstract:Compound 22 might become a novel antioxidant for the treatment of oxidative stress‐related diseases. Paeoniflorin (PF) is one of the active constituents of the traditional Chinese medicine Paeoniae Radix Rubra and has been actively explored in the pharmaceutical area due to its numerous pharmacological effects. However, severe difficulties such as limited bioavailability and low permeability limit its utilization. Therefore, this study developed and synthesized 25 derivatives of PF, characterized them by 1H NMR, 13C NMR, and HR‐MS, and evaluated their antioxidant activity. Firstly, the antioxidant capacity of PF derivatives was investigated through DPPH radical scavenging experiment, ABTS radical scavenging experiment, reducing ability experiment, and O2.− radical scavenging experiment. PC12 cells are routinely used to evaluate the antioxidant activity of medicines, therefore we utilize it to establish a cellular model of oxidative stress. Among all derivatives, compound 22 demonstrates high DPPH radical scavenging capacity, ABTS radical scavenging ability, reduction ability, and O2.− radical scavenging ability. The results of cell tests reveal that compound 22 has a non‐toxic effect on PC12 cells and a protective effect on H2O2‐induced oxidative stress models. This might be due to the introduction of 2, 5‐difluorobenzene sulfonate group in PF, which helps in scavenging free radicals under oxidative stress. Western blot and molecular docking indicated that compound 22 may exert antioxidant activity by activating Nrf2 protein expression. As noted in the study, compound 22 has the potential to be a novel antioxidant.
biochemistry & molecular biology,chemistry, medicinal